Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REV Group, Inc. | Director | Common Stock | 59.7K | $1.08M | $18.17 | Dec 8, 2023 | Direct |
REV Group, Inc. | Director | Restricted Stock Unit | 52.6K | Dec 8, 2022 | Direct | ||
Acasti Pharma Inc. | Director | Stock Options (Right to Buy) | 45K | Sep 28, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
REVG | REV Group, Inc. | Dec 8, 2023 | 1 | $0 | 4 | Dec 12, 2023 | Director |
REVG | REV Group, Inc. | Dec 8, 2022 | 1 | $0 | 4 | Dec 12, 2022 | Director |
ACST | Acasti Pharma Inc. | Sep 28, 2022 | 1 | $0 | 4 | Sep 30, 2022 | Director |
REVG | REV Group, Inc. | Dec 9, 2021 | 1 | $0 | 4 | Dec 13, 2021 | Director |
ACST | Acasti Pharma Inc. | Nov 12, 2021 | 1 | $0 | 4 | Nov 16, 2021 | Director |